课题基金 / 基金详情

项目摘要

项目成果

HAIG H. KAZAZIAN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):LINE-1或L1元件是哺乳动物基因组中最多产和最突出的移动的元件。在人类和小鼠的基因组中,活跃的L1及其遗迹占基因组质量的17-20%。通过为Alu和其他元素的移动提供必要的活动,它们间接地占这些基因组的另外10- 12%。L1反转录转座子通过复制和粘贴机制移动。在这个更新的建议,我们攻击一些悬而未决的问题,关于反转录转座的时间和细胞类型的特异性,L1插入到基因组中的机制,以及双向L1启动子在反转录转座控制中产生的siRNA的作用。在具体目标1中,我们试图确定男性生殖细胞、女性生殖细胞和胚胎发育早期发生的总逆转录转座事件的比例。我们还希望确定反转录转座是否随着年龄的增长而减少,在几代之后被抑制,并且由于甲基化或DMA双链断裂修复的缺陷而增加。在具体目标2中,我们进一步证明了来自L1双向启动子的siRNA的作用。我们还表征了来自L1 RNA的小RNA序列,并确定L1转录水平的特异性敲低是否会改变转化细胞的表型。在具体目标3中,我们将测试L1整合的新机制。该机制的假定特征是1)5'截短是由于L1 RNA的5'降解,2)逆转录酶的模板跳跃是该机制的关键特征,以及3)DMA第二链的合成是通过L1逆转录酶的DNA聚合酶活性进行的。在Specific Aim 3A中,我们确定了哪种RNA聚合酶转录L1以及RNA如何加工(加帽和聚腺苷酸化)。在特异性目标3B中,我们确定了L1 RNA降解所涉及的过程,特别是,是否涉及去腺苷化、去帽和5'降解,以及是否有显著部分的L1 RNA被快速5'降解。这些研究将大大增加我们对L1反转录转座生物学的了解。此外,他们将提供重要的新信息,努力使用L1作为一个随机插入诱变剂在哺乳动物。
英文摘要
DESCRIPTION (provided by applicant): LINE-1, or L1, elements, are the most prolific and prominent mobile elements in mammalian genomes. In the human and mouse genomes, active L1s and their relics account for 17-20% of the genome mass. By providing activities necessary for mobility of Alu and other elements, they indirectly account for another 10- 12% of these genomes. L1 retrotransposons move through a duplicative "copy and paste" mechanism. In this renewal proposal, we attack a number of unanswered questions concerning the timing and cell type specificity of retrotransposition, the mechanism of L1 insertion into the genome, and the role of siRNA produced by the bidirectional L1 promoter in the control of retrotransposition. In Specific Aim 1, we seek to determine the fraction of total retrotransposition events that occur in male germ cells, female germ cells, and in the early stages of embryonic development. We also wish to determine whether retrotransposition decreases with age, is suppressed after a number of generations, and is increased by defects in methylation or DMA double strand break repair. In Specific Aim 2 we develop further evidence of the role of siRNA derived from the L1 bidirectional promoter. We also characterize the small RNA sequences derived from L1 RNA, and determine whether specific knockdown of L1 transcript levels alters the phenotype of transformed cells. In Specific Aim 3, we will test a novel mechanism of L1 integration. Postulated features of this mechanism are 1) 5' truncation is due to 5' degradation of L1 RNA, 2) template jumping of reverse transcriptase is a key feature of the mechanism, and 3) synthesis of DMA second strand is carried out by a DNA polymerase activity of L1 reverse transcriptase. In Specific Aim 3A we determine which RNA polymerase transcribes L1 and how the RNA is processed (capped and polyadenylated). In Specific Aim 3B we determine the processes involved in L1 RNA degradation, in particular, whether deadenylation, decapping and 5' degradation are involved and whether a significant fraction of L1 RNA is rapidly 5' degraded. These studies will increase greatly our knowledge of the biology of L1 retrotransposition. In addition, they will provide important new information towards the effort to use L1 as a random insertional mutagen in mammals.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.gde.2012.02.006
发表时间: 2012-06
期刊: CURRENT OPINION IN GENETICS & DEVELOPMENT
影响因子: 4
作者: [Hancks, Dustin C., Kazazian, Haig H., Jr.]
通讯作者: Kazazian, Haig H., Jr.
An important role for RUNX3 in human L1 transcription and retrotransposition.
RUNX3 在人类 L1 转录和逆转录转座中发挥重要作用。
DOI: 10.1093/nar/gkg663
发表时间: 2003
期刊: Nucleic acids research
影响因子: 14.9
作者: [Yang,Nuo, Zhang,Lin, Zhang,Yue, KazazianJr,HaigH]
通讯作者: KazazianJr,HaigH
Retrotransposition in Health and Disease
  • 批准号:
    9105045
  • 项目类别:
  • 资助金额:
    $53.25万
  • 财政年份:
    2012
  • 负责人:
    HAIG H. KAZAZIAN
  • 依托单位:
Retrotransposition in Health and Disease
  • 批准号:
    8638030
  • 项目类别:
  • 资助金额:
    $47.73万
  • 财政年份:
    2012
  • 负责人:
    HAIG H. KAZAZIAN
  • 依托单位:
Retrotransposition in Health and Disease
  • 批准号:
    8826767
  • 项目类别:
  • 资助金额:
    $47.73万
  • 财政年份:
    2012
  • 负责人:
    HAIG H. KAZAZIAN
  • 依托单位:
Retrotransposition in Health and Disease
  • 批准号:
    8461147
  • 项目类别:
  • 资助金额:
    $46.06万
  • 财政年份:
    2012
  • 负责人:
    HAIG H. KAZAZIAN
  • 依托单位:
海外基金